title: Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene.
abstract: BACKGROUND
  Patients with a mutation in the LDL receptor gene (familial hypercholesterolemia, or FH) are characterized by substantial elevations in plasma LDL cholesterol and are at higher risk of developing coronary artery disease (CAD). Correlates of abdominal obesity may also contribute to the risk of ischemic cardiac events. Whether the hyperinsulinemic-insulin-resistant state of abdominal obesity affects coronary atherosclerosis among FH patients has not been determined.
  
  
  RESULTS
  The relation of abdominal adiposity and hyperinsulinemia to angiographically assessed CAD was evaluated in a sample of 120 French Canadian men aged <60 years who were heterozygotes for FH and in a group of 280 men without FH. In the present study, the risk of CAD associated with abdominal obesity, as estimated by the waist circumference, was largely dependent on the concomitant variation in plasma lipoprotein and insulin concentrations. In contrast, the association between fasting insulin and CAD was independent of variations in waist girth, triglyceride, HDL, and apolipoprotein B concentrations (odds ratio, 1.86; P=.0005). However, the most substantial increase in the risk of CAD was observed among abdominally obese (waist circumference >95 cm) and hyperinsulinemic FH patients (odds ratio, 12.9; P=.0009). This increase in risk remained significant even after adjustment for LDL cholesterol or apolipoprotein B concentrations.
  
  
  CONCLUSIONS
  Results of the present study provide support for the notion that the hyperinsulinemic-insulin-resistant state of abdominal obesity is a powerful predictor of CAD in men, even in a group of patients with raised LDL cholesterol concentrations due to FH.
authors.affiliation: Lipid Research Group, Chicoutimi Hospital, Québec, Canada. dgaudet@saglac.qc.ca
authors.forename: D
authors.initials: D
authors.lastname: Gaudet
authors.forename: M C
authors.initials: MC
authors.lastname: Vohl
authors.forename: P
authors.initials: P
authors.lastname: Perron
authors.forename: G
authors.initials: G
authors.lastname: Tremblay
authors.forename: C
authors.initials: C
authors.lastname: Gagné
authors.forename: D
authors.initials: D
authors.lastname: Lesiège
authors.forename: J
authors.initials: J
authors.lastname: Bergeron
authors.forename: S
authors.initials: S
authors.lastname: Moorjani
authors.forename: J P
authors.initials: JP
authors.lastname: Després
mesh_terms: D001824:Body Constitution; D016022:Case-Control Studies; D017023:Coronary Angiography; D003327:Coronary Disease / Q000097:blood / Q000000981:diagnostic imaging / Q000209:etiology*; D006801:Humans; D006946:Hyperinsulinism / Q000150:complications*; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000150:complications*; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009154:Mutation; D009765:Obesity / Q000150:complications*; D011973:Receptors, LDL / Q000235:genetics; D012307:Risk Factors
chemical_list: D007328:Insulin; D008055:Lipids; D011973:Receptors, LDL